Diclofenac Supplier-Buyer Network — Trade Flow Analysis

Name: Diclofenac Supplier-Buyer Trade Network Dataset — 1007+ Indian Exporters, 25+ Importers, 173+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Diclofenac supplier network, Diclofenac buyers, pharmaceutical export India, Diclofenac trade data

TransData Nexus

Diclofenac

India Pharmaceutical Trade Intelligence

$363.9M1,007 Suppliers173 CountriesHS 30049099

ExportsIndia → UNITED STATES25.1%India → TANZANIA13.3%

ImportsUNITED STATES → India$13.4M ISRAEL → India$658.0K

Who Supplies Diclofenac? Top Manufacturers & Buyers 2026 — LINCOLN PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD is the first-largest Diclofenac exporter from India, with a market share of 14.7% and a total export value of $53.6M across 179 shipments. Their average shipment value of $299.6K is above the market average of $24.3K, suggesting premium or bulk contract pricing.

LINCOLN PHARMACEUTICALS LTD serves 5 named buyers in our database. HEKO PHARMACY LTD is the dominant customer, accounting for 81.8% of this supplier's tracked business. Top customers include:

• HEKO PHARMACY LTD — $43.9M across 147 shipments (81.8% of this supplier's total exports)

• UNIVERSAL CO. LTD. — $5.9M across 20 shipments (11.1% of this supplier's total exports)

• PLANET PHARMA — $2.0M across 7 shipments (3.8% of this supplier's total exports)

• GENERICS & SPECIALIT — $974.3K across 3 shipments (1.8% of this supplier's total exports)

• TO THE ORDER — $798.6K across 3 shipments (1.5% of this supplier's total exports)

Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $299.6K is 1135% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.

2COMBITIC GLOBAL CAPLET PRIVATE LIMITED

COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the second-largest Diclofenac exporter from India, with a market share of 8.6% and a total export value of $31.4M across 216 shipments. Their average shipment value of $145.2K is above the market average of $24.3K, suggesting premium or bulk contract pricing.

COMBITIC GLOBAL CAPLET PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SHAMS NOORI PHARMA TRADING COMPANY — $14.1M across 97 shipments (45.0% of this supplier's total exports)

• SFS PHARM LLC — $13.9M across 96 shipments (44.3% of this supplier's total exports)

• OOO SMARTPHARMO — $2.9M across 20 shipments (9.3% of this supplier's total exports)

• WADAN KATAWAZ TRADIN — $340.5K across 2 shipments (1.1% of this supplier's total exports)

• MUHABAT LIMITED — $94.6K across 1 shipments (0.3% of this supplier's total exports)

Key Insight: COMBITIC GLOBAL CAPLET PRIVATE LIMITED's per-shipment value of $145.2K is 499% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.

3RUBICON RESEARCH PRIVATE LIMITED

RUBICON RESEARCH PRIVATE LIMITED is the third-largest Diclofenac exporter from India, with a market share of 5.8% and a total export value of $21.1M across 93 shipments. Their average shipment value of $226.6K is above the market average of $24.3K, suggesting premium or bulk contract pricing.

RUBICON RESEARCH PRIVATE LIMITED serves 5 named buyers in our database. RELIABLE HEALTHCARE LOGISTICS LLC is the dominant customer, accounting for 67.8% of this supplier's tracked business. Top customers include:

• RELIABLE HEALTHCARE LOGISTICS LLC — $14.3M across 63 shipments (67.8% of this supplier's total exports)

• TRIFLUENT PHARMA — $2.6M across 12 shipments (12.6% of this supplier's total exports)

• EVERSANA LIFE SCIENC — $1.9M across 9 shipments (9.2% of this supplier's total exports)

• SPYKA WHOLESALE INC — $1.8M across 8 shipments (8.5% of this supplier's total exports)

• INA PHARMACEUTICS IN — $407.0K across 2 shipments (1.9% of this supplier's total exports)

Key Insight: RUBICON RESEARCH PRIVATE LIMITED's per-shipment value of $226.6K is 834% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.

4CAPLIN POINT LABORATORIES LIMITED

CAPLIN POINT LABORATORIES LIMITED is the fourth-largest Diclofenac exporter from India, with a market share of 4.0% and a total export value of $14.6M across 310 shipments. Their average shipment value of $47.3K is above the market average of $24.3K, suggesting premium or bulk contract pricing.

CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. NUEVOS ETICOS NEOETHICALS, S.A. is the dominant customer, accounting for 69.7% of this supplier's tracked business. Top customers include:

• NUEVOS ETICOS NEOETHICALS, S.A. — $10.2M across 216 shipments (69.7% of this supplier's total exports)

• NEOETHICALS, S.A, — $2.3M across 48 shipments (15.5% of this supplier's total exports)

• NUEVOS ETICOS NEOETHICALS, S.A. — $927.2K across 20 shipments (6.3% of this supplier's total exports)

• DROGUERIA SAIMED S.A — $862.2K across 18 shipments (5.9% of this supplier's total exports)

• DROGUERIA SAIMED SA — $376.5K across 8 shipments (2.6% of this supplier's total exports)

Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $47.3K is 95% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.

5CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Diclofenac exporter from India, with a market share of 3.3% and a total export value of $11.8M across 1.1K shipments. Their average shipment value of $11.2K is below the market average of $24.3K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $11.7M across 1.0K shipments (98.5% of this supplier's total exports)

• ALJABAL DRUGS AND ME — $64.3K across 6 shipments (0.5% of this supplier's total exports)

• BREATHEFREE LANKA PR — $38.9K across 3 shipments (0.3% of this supplier's total exports)

• PHARMASCIENCE INC — $38.6K across 3 shipments (0.3% of this supplier's total exports)

• PHYSICIANS PHARMACEU — $35.8K across 3 shipments (0.3% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (1.1K shipments) at a per-shipment value of $11.2K, indicating a broad distribution network with many smaller, regular orders.

6TROIKAA PHARMACEUTICALS LIMITED

TROIKAA PHARMACEUTICALS LIMITED is the fifth-largest Diclofenac exporter from India, with a market share of 1.8% and a total export value of $6.4M across 471 shipments. Their average shipment value of $13.6K is below the market average of $24.3K, reflecting a high-volume, competitive pricing strategy.

TROIKAA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• PLANET PHARMA — $2.1M across 153 shipments (32.6% of this supplier's total exports)

• PLANET PHARMA — $1.9M across 139 shipments (29.5% of this supplier's total exports)

• PLANET PHARMA — $1.2M across 88 shipments (18.8% of this supplier's total exports)

• LLC SERENE PHARMA — $726.4K across 53 shipments (11.3% of this supplier's total exports)

• ABACUS PHARMA A LIMI — $504.0K across 37 shipments (7.8% of this supplier's total exports)

Key Insight: TROIKAA PHARMACEUTICALS LIMITED operates with high shipment frequency (471 shipments) at a per-shipment value of $13.6K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Diclofenac imports from India, with a total trade value of $91.2M across 1,311 shipments — representing a 25.1% share of all Diclofenac exports. The average shipment value of $69.6K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Diclofenac importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 22.5% ($20.5M) of this market's total imports.

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $20.5M (22.5% of United States's total)

• RELIABLE HEALTHCARE LOGISTICS LLC — $14.4M (15.8% of United States's total)

• AIM RX 3PL, LLC — $7.2M (7.9% of United States's total)

Key Insight: United States's per-shipment average of $69.6K (187% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Diclofenac imports from India.

Primary Market

Secondary Market

2Tanzania

Tanzania ranks as the second-largest destination for Diclofenac imports from India, with a total trade value of $48.6M across 54 shipments — representing a 13.3% share of all Diclofenac exports. The average shipment value of $899.5K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Diclofenac importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 92.8% ($45.1M) of this market's total imports.

• HEKO PHARMACY LTD — $45.1M (92.8% of Tanzania's total)

Key Insight: Tanzania's per-shipment average of $899.5K (3608% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tanzania is a key market for Diclofenac imports from India.

Primary Market

Secondary Market

3Uzbekistan

Uzbekistan ranks as the third-largest destination for Diclofenac imports from India, with a total trade value of $22.3M across 45 shipments — representing a 6.1% share of all Diclofenac exports. The average shipment value of $495.6K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Diclofenac importers in Uzbekistan: SFS PHARM LLC is the largest buyer, accounting for 62.8% ($14.0M) of this market's total imports.

• SFS PHARM LLC — $14.0M (62.8% of Uzbekistan's total)

• OOO SMARTPHARMO — $3.0M (13.2% of Uzbekistan's total)

• SHAYANA FARM LLC — $2.7M (12.1% of Uzbekistan's total)

Key Insight: Uzbekistan's per-shipment average of $495.6K (1943% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Uzbekistan is a key market for Diclofenac imports from India.

Primary Market

Secondary Market

4Ghana

Ghana ranks as the fourth-largest destination for Diclofenac imports from India, with a total trade value of $19.7M across 0 shipments — representing a 5.4% share of all Diclofenac exports. The average shipment value of $19.7M is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Ghana's per-shipment average of $19.7M (80931% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ghana is a key market for Diclofenac imports from India.

Primary Market

Secondary Market

5France

France ranks as the fifth-largest destination for Diclofenac imports from India, with a total trade value of $19.2M across 228 shipments — representing a 5.3% share of all Diclofenac exports. The average shipment value of $84.2K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Diclofenac importers in France: PLANET PHARMA is the largest buyer, accounting for 57.4% ($11.0M) of this market's total imports.

• PLANET PHARMA — $11.0M (57.4% of France's total)

• CENTRE SPECIALITES PHARMACEUTIQUES — $3.9M (20.3% of France's total)

Key Insight: France's per-shipment average of $84.2K (247% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Diclofenac imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Diclofenac.
2.Flow Mapping: 1007 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 15,000 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 173 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

15,000 Verified Shipments

1007 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Diclofenac

Diclofenac

Who Supplies Diclofenac? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Diclofenac — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Diclofenac? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Diclofenac Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1LINCOLN PHARMACEUTICALS LTD

2COMBITIC GLOBAL CAPLET PRIVATE LIMITED

3RUBICON RESEARCH PRIVATE LIMITED

4CAPLIN POINT LABORATORIES LIMITED

5CIPLA LIMITED

6TROIKAA PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Diclofenac Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Diclofenac Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Tanzania

3Uzbekistan

4Ghana

5France

People Also Ask — Diclofenac Supplier & Trade Network

Diclofenac Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology